Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Phospho-GSK-3-beta (Ser9) (D3A4) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-GSK-3α (Ser21) (36E9) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-GSK-3α (Ser21) (D1G2) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-GSK-3α/β (Ser21/9) (D17D2) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-GSK-3β (Ser9) (5B3) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-GSK-3β (Ser9) (D85E12) XP® Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Phospho-GSK-3β (Ser9) (D85E12) XP® Rabbit mAb (Alexa Fluor® 488 Conjugate)


Cell Signalling Technology logo
View Antibody details

Phospho-GSK-3β (Ser9) (D85E12) XP® Rabbit mAb (Alexa Fluor® 647 Conjugate)


Cell Signalling Technology logo
View Antibody details

Phospho-GSK-3β (Ser9) (D85E12) XP® Rabbit mAb (Pacific Blue™ Conjugate)


Cell Signalling Technology logo
View Antibody details

Phospho-GSK-3β (Ser9) (D85E12) XP® Rabbit mAb (PE Conjugate)


Cell Signalling Technology logo
View Antibody details